‘Simmonds’ will be the flagship restaurant for renowned chef Adam Simmonds, and will mark the start of his journey to infiltrate the UK food scene with his unique brand of eateries. ‘Simmonds’ aims to be London’s new destination restaurant of choice, and the first of a series of restaurants that combine innovative cooking with an outstanding memorable experience.
The CHF Media Fund offers an opportunity for UK Tax Payers to invest in both SEIS and EIS qualifying Family Entertainment companies, whilst also benefitting from risk mitigation in the form of S/EIS reliefs and Government backed animation Tax Credits. The Fund invests in companies which individually own the intellectual property rights to a family entertainment TV show or family entertainment concept.
Downing ONE VCT is one of the larger, more diversified Venture Capital Trusts (VCTs) in the UK with net assets of approximately £90 million. The Company is now seeking to raise up to £20 million to support the growth of existing portfolio companies and to take advantage of a strong pipeline of new investment opportunities.
A discretionary EIS & SEIS investment management service leveraging the experience and expertise of our investment team to select a diversified portfolio of the most promising companies that have passed through the GrowthInvest due diligence process. It is noted that both GrowthInvest and Sapphire Capital Partners LLP (the fund manager) have a material interest in this fund.
International Ambulances Limited (the “Company”) was formed in October 2016 by Phil Bevan to commercialise his revolutionary new ambulance design, the “ACESO”. Bevan Davidson International (“BDI”), a technology design and development company led by Phil, has been engaged on behalf of the Company to develop a concept prototype using the extensive experience they have gained in vehicle concept design and development.
Jenson SEIS & EIS Fund is a managed portfolio designed to provide increased diversification as a portfolio investment. The balance between capital growth, portfolio risk and time horizon is maximised, whilst enhancing the tax advantages available. This offering allows investors to choose whether they want to invest solely via SEIS or EIS or to split their funds across SEIS and EIS investments.
Mobeus, with an 18 year track record and excellent dividend history has returned to the market for the first time since 2015. Raising a total of £80m across its four VCT's, investments will be split between its mature portfolio and new growth investments. Benefit from the GrowthInvest discount alongside a further early bird discount of 1% available until the 1st November.
The Boxing Advantage Company Limited (“the Company”) operates in the boxing arena and offers a pioneering concept. The Company will represent boxers across weight-classes by scouting, training and mentoring and developing the best young talent it can find and promote its boxers to maximise sponsorship and advertising revenues.
The Symvan Technology EIS Fund (the “Fund”) has been established to enable investors to invest in technology companies with high growth potential. Symvan Capital Limited (the “Manager” or “Symvan Capital”) considers that companies in the technology sector that have high growth potential and which also qualify for EIS tax reliefs which fit with the Fund’s focused investment criteria have the potential to offer investors an attractive return.
Unicorn AIM VCT is the largest VCT specialising in AIM-listed companies, with over £162.4m AUM, and won 'Best VCT’ in the Investment Company of the Year Awards. The current £30 million share issue is available to GrowthInvest clients who benefit from a 3% GrowthInvest discount when investing.
Veloscient is clinical notes for mobiles. It liberates hours each day, unlocking a $60 billion market with a mobile App that eliminates keyboards. Its UI breakthrough allows the capture of narrative and logic to configure the mobile App - what takes many minutes of typing can be compiled in seconds using any device’s touch screen. The captured narratives can be shared and optimized to transform care. With freemium pricing adoption is easy.